Company intelligence / Profile preview
Marlex Pharmaceuticals
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
Overview
Marlex Pharmaceuticals is a commercial-stage pharmaceutical company specializing in the manufacture, packaging, and distribution of over 100 generic, consumer, and specialty pharmaceutical products. Their portfolio includes more than 60 solid-dose over-the-counter formulations comparable to national brands. The company serves hospitals, nursing homes, home health providers, wholesalers, and other healthcare entities across the United States. In September 2023, Marlex recalled two lots of digoxin tablets due to a labeling mix-up between different dosages.
- Therapeutic areas
- CardiovascularImmunologyNeurologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Marlex Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Marlex Pharmaceuticals.